Far-infrared Ray Effect on CV12 Acupoint

This study has been completed.
Sponsor:
Information provided by:
China Medical University Hospital
ClinicalTrials.gov Identifier:
NCT01339728
First received: April 14, 2011
Last updated: April 20, 2011
Last verified: April 2011
  Purpose

The purpose of the present study was to investigate the effect of far-infrared ray at CV12 acupoints area on the skin temperature and skin blood flow of palm central area of right hand, and the correlation between them.


Condition Intervention
Reaction of Far Infrared Ray
Reaction of Skin Temperature
Procedure: far-infrared ray

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Basic Science
Official Title: Far-infrared Ray Illuminates Area of CV12 Acupoint to Investigate the Correlation of Skin Temperature and Skin Blood Flow Between CV12 Acupoint and Palm Central Part of Right Hand

Further study details as provided by China Medical University Hospital:

Primary Outcome Measures:
  • far-infrared ray on CV12 acupoint area may increase the skin temperature [ Time Frame: Each period was 20 min in duration ] [ Designated as safety issue: No ]

Enrollment: 22
Study Start Date: October 2010
Study Completion Date: April 2011
Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)
Intervention Details:
    Procedure: far-infrared ray
    The duration of far-infrared ray is 20 minutes.
Detailed Description:

The purpose of the present study was to investigate the effect of far-infrared ray at CV12 acupoints area (the center is CV12 acupoints and the diameter is 10 cm) on the skin temperature and skin blood flow of palm central area of right hand, and the correlation between them.

  Eligibility

Ages Eligible for Study:   20 Years to 40 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy adult volunteers, male or female, ages between 20 and 40 years
  • Neurological and physical examination without abnormal functions
  • Far-infrared ray illumination without allergic reaction and contra- indication
  • The participants were explained the objective of the study, agreed to accept the test and signed a letter of consent

Exclusion Criteria:

  • People less than 20 years of age or more than 40 years
  • Women in pregnant or lactating
  • People with mental or behavioral anomalies could not follow the researchers
  • People suffered from serious diseases such as myocardial infarction , heart failure, serious arrhythmia, hypertension, diabetes, autoimmune disease, chronic obstructive pulmonary diseases, and kidney failure, liver cirrhosis and cancer
  • People suffered from limb edema and serious skin diseases
  • People did not sign a letter of consent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01339728

Locations
Taiwan
China Medical University Hospital
Taichung, Taiwan, 404
Sponsors and Collaborators
China Medical University Hospital
Investigators
Study Chair: Ching-Liang Hsieh, professor China Medical University Hospital
  More Information

No publications provided

Responsible Party: Ching-Liang Hsieh, China Medical University Hospital
ClinicalTrials.gov Identifier: NCT01339728     History of Changes
Other Study ID Numbers: DMR99-IRB-176-1
Study First Received: April 14, 2011
Last Updated: April 20, 2011
Health Authority: Taiwan: Institutional Review Board

ClinicalTrials.gov processed this record on July 20, 2014